Tandem Diabetes Care Inc (BSP:T2ND34)
R$ 5.8 -0.38 (-6.15%) Market Cap: 397.47 Mil Enterprise Value: 1.23 Bil PE Ratio: 0 PB Ratio: 8.86 GF Score: 45/100

Tandem Diabetes Care Inc at Citi Healthcare & Medtech Conference Transcript

Mar 02, 2023 / 07:45PM GMT
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

My back is killing me. But anyway, so I want to talk a little bit about the insulin pump market.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

First of all, hi, Joanne.

Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Hi.

Leigh A. Vosseller
Tandem Diabetes Care, Inc. - Executive VP, CFO & Treasurer

Thank you for having us.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Good to see all you guys.

Questions & Answers

Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Insulin pump market okay?

John F. Sheridan;Joanne Karen Wuensch
Tandem Diabetes Care, Inc. - President, CEO & Director;Citigroup Inc., Research

Yes, insulin pump market is good.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot